Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
27 July 2016Website:
http://www.pavmed.comNext earnings report:
14 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 82 min agoDividend
Analysts recommendations
Institutional Ownership
PAVM Latest News
Efforts include appointment of seasoned biotech investor Sundeep Agrawal, M.D. to board to replace departing directors NEW YORK , Sept.
PAVmed Inc. (NASDAQ:PAVM ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Matt Riley - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Conference Call Participants Matthew Park - Cantor Fitzgerald Anthony Vendetti - Maxim Group Ed Woo - Ascendiant Capitalized Operator Good morning and welcome to PAVmed's Second Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.
A conference call and webcast will be held at 8:30 AM Eastern Time on May 14, 2024 by PAVmed Inc. to provide a business update.
PAVmed Inc. (PAVM) ended the most recent trading session at $2.07, showing a decrease of 1.43% from the previous day.
PAVmed Inc. (NASDAQ:PAVM ) Q3 2023 Earnings Call Transcript November 15, 2023 8:30 AM ET Company Participants Michael Parks - Vice President of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - Executive Vice President and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Ed Woo - Ascendiant Capital Anthony Vendetti - Maxim Group Operator Good day, and welcome to the PAVmed Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode.
PAVmed Inc. (PAVM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
PAVmed Inc. (NASDAQ:PAVM ) Q2 2023 Earnings Conference Call August 16, 2023 8:30 AM ET Company Participants Michael Parks - Vice President of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - Executive Vice President and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Ed Woo - Ascendiant Capital Ross Osborn - Cantor Fitzgerald Anthony Vendetti - Maxim Group Operator Good day, and welcome to the PAVmed Second Quarter 2023 Business Update Conference Call. [Operator Instructions] Please note, today's event is being recorded.
What type of business is PAVmed?
PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
What sector is PAVmed in?
PAVmed is in the Healthcare sector
What industry is PAVmed in?
PAVmed is in the Medical Devices industry
What country is PAVmed from?
PAVmed is headquartered in United States
When did PAVmed go public?
PAVmed initial public offering (IPO) was on 27 July 2016
What is PAVmed website?
https://www.pavmed.com
Is PAVmed in the S&P 500?
No, PAVmed is not included in the S&P 500 index
Is PAVmed in the NASDAQ 100?
No, PAVmed is not included in the NASDAQ 100 index
Is PAVmed in the Dow Jones?
No, PAVmed is not included in the Dow Jones index
When was PAVmed the previous earnings report?
No data
When does PAVmed earnings report?
The next expected earnings date for PAVmed is 14 November 2024